Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing tamoxifen therapy through rifampicin-induced CYP metabolism
2010-023776-52Phase 4Active
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tamoxifen in breast cancer (2 arms). Primary endpoints: Effect of rifampicin-induced CYP enzymes on tamoxifen pharmacokinetics and Side-effect profile of tamoxifen with and without rifampicin. Started Nov 2010; status: active.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2010-023776-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023776-52.